With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Chambers UK, 2018
Chambers Europe-wide, 2018
Legal 500, 2018
Chambers Asia-Pacific, 2018
Chambers Global- wide, 2018
Almost two years ago, the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).
Since liberalisation at the beginning of 2017, industrial and medical Cannabis have experienced a boom in Germany.
Each Belgian biobank will have to be declared at the Federal Agency for Medicines and Health Products (FAMHP) in order to operate. It also imposes binding content for agreements on the transfer of human biological ...
International law firm Bird & Bird today boosts its Corporate practice with the appointment of life sciences expert Michiel Wurfbain as a partner in The Hague.
Bird & Bird are pleased to announce the promotion of three partners, as well as eight Senior Counsel/Counsel/Legal Directors from across our global offices.
International law firm Bird & Bird today expands its Corporate practice group with the appointment of James Baillieu as a partner in London.
There are no forthcoming events for this area. Please click on the button below to view past events.
Australia's new Therapeutic Goods Advertising Code effective 1 January 2019: https://t.co/QAhNnqkMVU
RT @LSXLeaders: Download the brochure to see who's already coming to the LSX World Congress 2019: https://t.co/8AVOjj1jnw #LSXWORLD https:/…
RT @LifeSciencesIPR: ' A Perspective on Recent UK Supreme Court Caselaw': Chris de Mauny, Associate, Barrister, Bird & Bird takes us throug…